Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Rocket Pharmaceuticals is a biotech company specializing in developing gene therapies for rare, devastating diseases. Its focus includes in vivo AAV-based treatments for conditions like Danon disease and cardiomyopathies, as well as ex vivo lentiviral programs for hematologic disorders such as Fanconi anemia and LAD-I. The company aims to deliver potentially curative, first-in-class therapies targeting unmet medical needs in pediatric and adult patients worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.